Working… Menu

PTC299 for Treatment of Neurofibromatosis Type 2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00911248
Recruitment Status : Terminated
First Posted : June 1, 2009
Last Update Posted : April 12, 2019
United States Department of Defense
Information provided by (Responsible Party):
PTC Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 31, 2012
Actual Study Completion Date : March 31, 2012
Certification/Extension First Submitted : April 9, 2019